Baker Julian's Form 4 filing
Kodiak Sciences Inc. (KOD) · filed May 18, 2022
- Accession no.
- 0001209191-22-030150
- Filed
- May 18, 2022, 5:30 PM ET
- Trade date
- May 16-18, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions and 0 derivative transactions. Open-market purchases total $2.70M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baker JulianCIK 0001087939 | Director, 10% Owner |
| Baker FelixCIK 0001087940 | Director, 10% Owner |
| Baker Bros. Advisors LPCIK 0001263508 | Director, 10% Owner |
| Baker Brothers Life Sciences LPCIK 0001363364 | Director, 10% Owner |
| 667, L.P.CIK 0001551139 | Director, 10% Owner |
| Baker Bros. Advisors (GP) LLCCIK 0001580575 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2022 | Common Stock | PPurchaseAcquired | +11,410 | $5.71 | +$65,152.24 | 1,207,490 | Indirect | |
| May 16, 2022 | Common Stock | PPurchaseAcquired | +93,690 | $5.71 | +$534,979.27 | 14,828,655 | Indirect | |
| May 16, 2022 | Common Stock | PPurchaseAcquired | +1,846 | $5.75 | +$10,609.89 | 1,209,336 | Indirect | |
| May 16, 2022 | Common Stock | PPurchaseAcquired | +15,154 | $5.75 | +$87,097.62 | 14,843,809 | Indirect | |
| May 17, 2022 | Common Stock | PPurchaseAcquired | +989 | $5.99 | +$5,920.75 | 1,210,325 | Indirect | |
| May 17, 2022 | Common Stock | PPurchaseAcquired | +8,118 | $5.99 | +$48,599.22 | 14,851,927 | Indirect | |
| May 17, 2022 | Common Stock | PPurchaseAcquired | +11,043 | $5.99 | +$66,122.17 | 1,221,368 | Indirect | |
| May 17, 2022 | Common Stock | PPurchaseAcquired | +90,674 | $5.99 | +$542,928.71 | 14,942,601 | Indirect | |
| May 18, 2022 | Common Stock | PPurchaseAcquired | +1,115 | $5.95 | +$6,638.38 | 1,222,483 | Indirect | |
| May 18, 2022 | Common Stock | PPurchaseAcquired | +9,157 | $5.95 | +$54,518.03 | 14,951,758 | Indirect | |
| May 18, 2022 | Common Stock | PPurchaseAcquired | +22,266 | $5.97 | +$132,896.85 | 1,244,749 | Indirect | |
| May 18, 2022 | Common Stock | PPurchaseAcquired | +182,827 | $5.97 | +$1,091,221.23 | 15,134,585 | Indirect | |
| May 18, 2022 | Common Stock | PPurchaseAcquired | +912 | $5.97 | +$5,443.64 | 1,245,661 | Indirect | |
| May 18, 2022 | Common Stock | PPurchaseAcquired | +7,489 | $5.97 | +$44,701.09 | 15,142,074 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.